ABP 798

Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study
Endpoints
Thu, 08/22/19 - 11:54 am
Novartis
Amgen
Allergan
biosimilars
Roches
Rituxan
ABP 798